NEW YORK, Dec. 12 – Celera Genomics and Merck said Wednesday that they had agreed to extend their osteoporosis drug discovery deal for a sixth year.

This is the fourth extension for the research collaboration. The original deal dates back to November 1996 when Celera’s South San Francisco operations, then Axys Pharmaceuticals, penned a two-year drug discovery deal with Merck.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.